Company News

PharmaTimes reports that KKR has agreed to take over ReSearch Pharmaceutical Services (RPS) from its private-equity owner, Warburg Pincus.

PharmaTimes reports that KKR has agreed to take over ReSearch Pharmaceutical Services (RPS) from its private-equity owner, Warburg Pincus. No financial details of the offer were disclosed.

As reported in the market news:

The transaction will bring together “two highly complementary companies with PRA as a leader in traditional programmatic outsourced clinical development and RPS as a pioneer of the innovative Embedded clinical development model,” commented Jim Momtazee, head of KKR’s Health Care investing team.

Click here to read the full news story on PharmaTimes

MARKETS

Markets
TSX19022.86-40.31
TSXV615.38+1.18
DOW31338.15-46.40
S&P 5003899.38-3.24
NASD11635.31+13.96
ASX6678.00+30.00

COMMODITIES

Commodities
Gold1742.35+0.55
Silver19.32+0.02
Copper3.52-0.05
Palladium2186.50+11.74
Platinum899.32+2.68
Oil104.80+2.07
Heating Oil3.670.00
Natural Gas6.07-0.23

DOWNLOAD FREE REPORTS

×